Cancer

Higher lifetime alcohol consumption linked to colorectal cancer risk

by Wiley edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Studies have demonstrated a link between alcohol consumption and an elevated risk of colorectal cancer. New research now reveals that higher lifetime alcohol consumption is also associated with a higher risk, especially for rectal cancer, and […]

Higher lifetime alcohol consumption linked to colorectal cancer risk Read More »

Discovery illuminates how inflammatory bowel disease promotes colorectal cancer

January 23, 2026 / Cancer, Research update / InnovateMed Author / colorectal cancer

by Weill Cornell Medical College edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Enhanced image showing where genes are active in colon tissue, revealing neutrophils located close to pre-cancerous epithelial cells. Credit: Longman lab. A chain of immune reactions in the gut—driven by a key signaling protein and a surge of

Discovery illuminates how inflammatory bowel disease promotes colorectal cancer Read More »

Inflammatory pathway reveals targetable weakness in hard-to-treat blood cancer

January 20, 2026 / Cancer, Research update / InnovateMed Author / blood cancer

by Indiana University edited by Robert Egan Editors’ notes The GIST Add as preferred source Kate Ho is working in the lab. Credit: Indiana University New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia by identifying the blood cancer’s reliance on a specific signaling pathway involved in the

Inflammatory pathway reveals targetable weakness in hard-to-treat blood cancer Read More »

Most elderly cancer patients receive inappropriate drugs until final months, study finds

January 20, 2026 / Cancer, Research update / InnovateMed Author / cancer patient

by University of Tsukuba edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Analysis of the medical records of 1,269 elderly patients with advanced cancer by researchers at the University of Tsukuba has found that more than 70% were prescribed potentially inappropriate medications (PIMs) and that the

Most elderly cancer patients receive inappropriate drugs until final months, study finds Read More »

Predicting prostate cancer recurrence through power of AI

January 15, 2026 / Artificial Intelligence, Cancer, Research update / InnovateMed Author / prostate cancer

edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department of Radiation Oncology developed the PSA Control Tower. This is

Predicting prostate cancer recurrence through power of AI Read More »

Study Adds Evidence That Nicotinamide Prevents Skin Cancers

December 29, 2025 / Cancer, Clinical Practice / InnovateMed Author / skin cancer

Richard Mark Kirkner September 22, 2025 A large retrospective study of Veterans Affairs patients with a history of skin cancer has provided support to what a smaller randomized clinical trial reported about a decade ago: that patients taking nicotinamide 500 mg twice daily can significantly reduce their risk for skin cancer, with the greatest effect

Study Adds Evidence That Nicotinamide Prevents Skin Cancers Read More »

Colorectal cancer’s immune puzzle cracked: Two Treg cell types shape survival odds

December 16, 2025 / Cancer, Research update / InnovateMed Author / colorectal cancer

by Ian Demsky, Memorial Sloan Kettering Cancer Center edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system’s ability to fight against a tumor. Colorectal cancer, however, is a puzzling exception. A

Colorectal cancer’s immune puzzle cracked: Two Treg cell types shape survival odds Read More »

Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

December 16, 2025 / Cancer, Research update / InnovateMed Author / immune activation

by Harvard University edited by Gaby Clark, reviewed by Robert Egan The personalized biomaterial-based cancer vaccine consists of a porous biomaterial scaffold the size of an aspirin tablet that is infused with immune cell-recruiting and activating molecules and inactivated tumor antigens derived from tumors of the trial participants. Credit: Wyss Institute at Harvard University The first-in-human clinical phase

Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation Read More »

AI can help cancer patients better understand CT reports

November 21, 2025 / Artificial Intelligence, Cancer, Clinical Practice / InnovateMed Author / CT reports

by Paul Hellmich, Technical University Munich edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: CC0 Public Domain Medical reports written in technical terminology can pose challenges for patients. A team at the Technical University of Munich (TUM) has investigated how artificial intelligence can make CT findings easier to understand. In the study, reading time decreased,

AI can help cancer patients better understand CT reports Read More »

New therapeutic strategies show promise against a hard-to-treat prostate cancer

November 20, 2025 / Cancer, Research update / InnovateMed Author / prostate cancer

by McGill University edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes Credit: cottonbro studio from Pexels A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI) identified a mechanism driving neuroendocrine prostate cancer, a rare and highly

New therapeutic strategies show promise against a hard-to-treat prostate cancer Read More »